• Share
  • Email
  • Print
Get Connected
Government Enforcement Alert

Pharmaceutical Diversion – Risks and Steps to Address a Major DEA Focus

Patrick C. McCooe, Michael D. Ricciuti
21 March 2016

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm’s clients.

If you are having difficulty printing this article, please use Internet Explorer.